The Central Bright Spot Sign: A Potential New MR Imaging Sign for the Early Diagnosis of Anterior Ischemic Optic Neuropathy due to Giant Cell Arteritis.
P RemondArnaud AttyéAugustin LeclerL LamalleN BoudiafFlorent AptelAlexandre KrainikChristophe ChiquetPublished in: AJNR. American journal of neuroradiology (2017)
Here, we provide evidence of a new MR imaging sign that identifies the acute stage of giant cell arteritis-related anterior ischemic optic neuropathy; patients without this central bright spot sign always had a nonarteritic pathophysiology and therefore did not require emergency corticosteroid therapy.
Keyphrases
- giant cell
- end stage renal disease
- ejection fraction
- newly diagnosed
- contrast enhanced
- public health
- healthcare
- chronic kidney disease
- liver failure
- prognostic factors
- genome wide
- magnetic resonance imaging
- intensive care unit
- cerebral ischemia
- risk assessment
- mesenchymal stem cells
- bone marrow
- patient reported outcomes
- oxidative stress
- human health
- cell therapy
- hepatitis b virus
- mechanical ventilation